The old proverb “Don’t judge a book by its cover” is meant to discourage people from drawing conclusions about someone based on their outward appearance. However, a new study suggests that there is a certain amount of information to be gained from observing a person’s exterior features. Specifically, it’s possible to determine if someone is rich or poor based on their facial expression.
The study was done by researchers at the Faculty of Arts and Science at the University of Toronto. Posting their findings in the Journal of Personality and Social Psychology, the results have significance to anyone who might be wondering why opportunities keep evading them. For one thing, being judged based on one’s facial expression can lead to rejection when applying for a job.
The researchers basically conducted an investigation using photos of two individuals and had “perceivers” judge these subjects’ socioeconomic standing. A neutral expression was necessary because it produced more telling results.
“Indeed, neutrally posed rich targets displayed more positive affect relative to poor targets and perceivers used this affective information to categorize their social class,” the paper reads. “Impressions of social class from these facial cues also influenced participants’ evaluations of the targets’ employability, demonstrating that face-based perceptions of social class may have important downstream consequences”
In its essence, the study proposes that by simply looking at a face with a “neutral” expression, it is possible to determine that person’s financial situation. As Thora Bjornsdottir, one of the researchers behind the study notes, even the smallest of details regarding the face can influence numerous aspects of life, Phys.org reports.
"It indicates that something as subtle as the signals in your face about your social class can actually then perpetuate it," Bjornsdottir said. "Those first impressions can become a sort of self-fulfilling prophesy. It's going to influence your interactions, and the opportunities you have."


FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tabletop particle accelerator could transform medicine and materials science
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028 



